FDA Warns of Bladder Cancer Risk With Actos

Patients taking the diabetes drug Actos for more than a year may have an increased risk of bladder cancer, according to an FDA interim review of an ongoing epidemiological study. The warning comes just days after two European countries banned use of the drug. The European Medicines Agency (EMA) has yet to release any guidance on use of Actos. Five-year data show that although there's no overall increased risk of bladder cancer, patients with the longest exposure to and the highest cumulative...Full Story
Commenting on this article is closed.